Patent · US Active

Bacteria engineered to reduce hyperphenylalaninemia

US11618894B2 · kind B2 · utility

2Cited by

15References

33Claims

0Family size

Assignee

Synlogic Operating Company, Inc. · US

Inventors

Dean Falb · Sherborn, US
Vincent M. Isabella · Medford, US
Jonathan W. Kotula · Somerville, US
Paul F. Miller · Salem, US
Sarah Rowe · Somerville, US
Yves Millet · Newton, US

Key dates

Filing date	Nov 16, 2016
Grant date	Apr 4, 2023
Priority date	—
Expiry date	Nov 16, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.